Free Trial

NKGen Biotech (NKGNW) Competitors

$0.04 -0.01 (-12.89%)
(As of 12/20/2024 05:16 PM ET)

NKGNW vs. ATNFW, SXTPW, DRTSW, WENAW, APLMW, BCTXW, CDIOW, CTCXW, CELUW, and CEROW

Should you be buying NKGen Biotech stock or one of its competitors? The main competitors of NKGen Biotech include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), and CERo Therapeutics (CEROW). These companies are all part of the "biotechnology" industry.

NKGen Biotech vs.

NKGen Biotech (NASDAQ:NKGNW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, valuation, profitability, community ranking, institutional ownership, earnings and analyst recommendations.

In the previous week, NKGen Biotech's average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
NKGen Biotech Neutral
180 Life Sciences Neutral

Company Net Margins Return on Equity Return on Assets
NKGen BiotechN/A N/A N/A
180 Life Sciences N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NKGen Biotech$77KN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

NKGen Biotech and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
NKGen BiotechN/AN/A
180 Life SciencesN/AN/A

Summary

NKGen Biotech beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NKGNW vs. The Competition

MetricNKGen BiotechBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$165.68M$5.14B$9.08B
Dividend YieldN/A3.64%5.09%4.23%
P/E RatioN/A115.5190.0517.18
Price / SalesN/A18,531.021,116.25117.05
Price / CashN/A12.8743.1037.85
Price / BookN/A8.594.784.78
Net IncomeN/A-$20.67M$120.31M$225.60M
7 Day PerformanceN/A-1.05%-1.92%-1.23%
1 Month PerformanceN/A174.77%13.65%0.46%
1 Year PerformanceN/A134.18%28.34%15.24%

NKGen Biotech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NKGNW
NKGen Biotech
N/A$0.04
-12.9%
N/A-64.4%$0.00$77,000.000.0063Gap Down
High Trading Volume
ATNFW
180 Life Sciences
N/A$0.01
-16.5%
N/A+31.6%$0.00N/A0.007Positive News
Gap Down
SXTPW
60 Degrees Pharmaceuticals
N/A$0.02
+0.7%
N/A-56.7%$0.00$502,409.000.002Positive News
Gap Down
DRTSW
Alpha Tau Medical
N/A$0.24
+4.1%
N/A+68.4%$0.00N/A0.0080Positive News
Gap Down
WENAW
Anew Medical
N/A$0.04
-0.3%
N/AN/A$0.00N/A0.00N/AGap Down
APLMW
Apollomics
N/A$0.01
-6.0%
N/A-45.9%$0.00N/A0.0059News Coverage
Gap Up
BCTXW
BriaCell Therapeutics
N/A$0.50
+14.4%
N/A-82.3%$0.00N/A0.008High Trading Volume
CDIOW
Cardio Diagnostics
N/A$0.06
+0.2%
N/A-34.7%$0.00$35,688.000.007Positive News
Gap Up
High Trading Volume
CTCXW
Carmell
N/A$0.04
+4.9%
N/AN/A$0.00$32,839.000.009Positive News
Gap Down
CELUW
Celularity
N/A$0.02
+5.8%
N/A-19.6%$0.00$42.69M0.00220Positive News
Gap Up
CEROW
CERo Therapeutics
N/A$0.01
+30.6%
N/AN/A$0.00N/A0.008Gap Down
High Trading Volume

Related Companies and Tools


This page (NASDAQ:NKGNW) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners